Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs
May 30, 2024 16:05 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced the appointment of Robert M. Cuddihy, M.D., as senior vice president of Medical Affairs....
Kahuna Enters Into Collaboration With Mayo Clinic To Transform Clinical Orientation and Digitized Competency Management
May 30, 2024 10:09 ET
|
Kahuna Workforce Solutions
Kahuna's competency management and Mayo Clinic's TSAM® Orientation Model provide a starting point for health systems to digitize nursing competencies.
World Immuno-Oncology Diagnostics Market Forecasts Report 2024: The Disruption Dynamic, The Race for Biomarkers, The Next Five Years
May 28, 2024 09:06 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis" report has been added to ...
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
May 24, 2024 08:00 ET
|
BriaCell Therapeutics Corp.
83% intracranial objective response rate (iORR) with Bria-IMT™ in heavily pretreated advanced breast cancer patients with CNS metastasesMedian progression free survival (PFS) of 4.1 months in ADC...
Enterome Highlights High Complete Response Rate in Clinical Study of EO2463 for Indolent Non-Hodgkin Lymphoma at ASCO 2024
May 24, 2024 06:00 ET
|
Enterome
- Beneficial clinical responses observed with EO2463 monotherapy already at 6 weeks and complete response rate of 78% in patients treated with EO2463 upon addition of lenalidomide ± rituximab - ...
HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
May 23, 2024 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 23, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from...
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
May 23, 2024 08:00 ET
|
Trinity Biotech plc
-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million by Q2 2025- -Strong sequential 39% Q/Q growth...
Medical Second Opinion Market Size to Worth USD 20.45 Bn By 2031
May 21, 2024 11:56 ET
|
CMI
Burlingame, May 21, 2024 (GLOBE NEWSWIRE) -- The global Medical Second Opinion Market is projected to grow from USD 7.12 billion in 2024, and it is projected to reach USD 20.45 billion by 2031, at a...
Computed Tomography Industry Research 2024: Global Market to Reach $10.21 Billion by 2033, Driven by Partnerships and Collaborations, and Increasing Product Approval Leading to Various New Offerings
May 20, 2024 06:14 ET
|
Research and Markets
Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "Computed Tomography Market - A Global and Regional Analysis: Focus on Type, Technology, End User, and Country - Analysis and Forecast, 2024-2033" report...
Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
May 16, 2024 09:18 ET
|
Trinity Biotech plc
DUBLIN, Ireland, May 16, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions,...